Edesa Biotech Extends COVID-19 Clinical Study to Poland

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. NVDA
6. WYFI
7. STUB
8. EAT
9. BTGO
10. GO

Go back to Edesa Biotech Extends COVID-19 Clinical Study to Poland
(NASDAQ: EDSA) Delayed: 5.38 +0.08 (1.51%)
Previous Close $5.30    52 Week High $ 
Open $5.37    52 Week Low $ 
Day High $5.72    P/E N/A 
Day Low $5.30    EPS $ 
Volume 21,857